Valcyte and Left ventricular hypertrophy - a phase IV clinical study of FDA data


Left ventricular hypertrophy is found among people who take Valcyte, especially for people who are male, 60+ old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Valcyte and have Left ventricular hypertrophy. It is created by eHealthMe based on reports of 5,910 people who have side effects when taking Valcyte from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Oct, 01, 2022

5,910 people reported to have side effects when taking Valcyte.
Among them, 46 people (0.78%) have Left ventricular hypertrophy.

What is Valcyte?

Valcyte has active ingredients of valganciclovir hydrochloride. It is often used in cmv - immunocompromised host. eHealthMe is studying from 5,946 Valcyte users for its effectiveness, alternative drugs and more.

What is Left ventricular hypertrophy?

Left ventricular hypertrophy (the thickening of the myocardium (muscle) of the left ventricle of the heart) is found to be associated with 1,485 drugs and 718 conditions by eHealthMe.

Number of Valcyte and Left ventricular hypertrophy reports submitted per year:

Could Valcyte cause Left ventricular hypertrophy?

Time on Valcyte when people have Left ventricular hypertrophy *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Left ventricular hypertrophy when taking Valcyte *:

  • female: 11.36 %
  • male: 88.64 %

Age of people who have Left ventricular hypertrophy when taking Valcyte *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 2.5 %
  • 40-49: 20.0 %
  • 50-59: 10.0 %
  • 60+: 67.5 %

Common drugs people take besides Valcyte *:

  1. Tacrolimus: 34 people, 73.91%
  2. Pantoprazole: 30 people, 65.22%
  3. Sodium Bicarbonate: 27 people, 58.70%
  4. Prograf: 24 people, 52.17%
  5. Candesartan Cilexetil: 23 people, 50.00%
  6. Hygroton: 22 people, 47.83%
  7. Furosemide: 22 people, 47.83%
  8. Myfortic: 22 people, 47.83%
  9. Torsemide: 22 people, 47.83%
  10. Carvedilol: 22 people, 47.83%

Common side effects people have besides Left ventricular hypertrophy *:

  1. High Blood Pressure: 36 people, 78.26%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 35 people, 76.09%
  3. Thrombosis (formation of a blood clot inside a blood vessel): 33 people, 71.74%
  4. Dizziness: 31 people, 67.39%
  5. Headache (pain in head): 30 people, 65.22%
  6. Insomnia (sleeplessness): 30 people, 65.22%
  7. Swelling Face: 29 people, 63.04%
  8. Agitation (state of anxiety or nervous excitement): 28 people, 60.87%
  9. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 28 people, 60.87%
  10. Bradycardia (abnormally slow heart action): 27 people, 58.70%

Common conditions people have *:

  1. High Blood Cholesterol: 22 people, 47.83%
  2. Fluid Retention (an abnormal accumulation of fluid in the blood): 22 people, 47.83%
  3. Cardiac Disorder: 22 people, 47.83%
  4. Prostate Infection: 21 people, 45.65%
  5. Abdominal Discomfort: 21 people, 45.65%
  6. High Blood Pressure: 9 people, 19.57%
  7. Fabry's Disease (build up of a particular type of fat, called globotriaosylceramide, in the body's cells): 4 people, 8.70%
  8. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 2.17%
  9. Prostatic Disorder: 1 person, 2.17%
  10. Cardiomyopathy (weakening of the heart muscle): 1 person, 2.17%

* Approximation only. Some reports may have incomplete information.

Do you take Valcyte and have Left ventricular hypertrophy?

Check whether Left ventricular hypertrophy is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Left ventricular hypertrophy and when was it recovered:

Expand to all the drugs that have ingredients of valganciclovir hydrochloride:

Alternative drugs to, pros and cons of Valcyte:

Common Valcyte side effects:

Browse all side effects of Valcyte:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Left ventricular hypertrophy treatments and more:

COVID vaccines that are related to Left ventricular hypertrophy:

Common drugs associated with Left ventricular hypertrophy:

All the drugs that are associated with Left ventricular hypertrophy:

Common conditions associated with Left ventricular hypertrophy:

All the conditions that are associated with Left ventricular hypertrophy:

How the study uses the data?

The study uses data from the FDA. It is based on valganciclovir hydrochloride (the active ingredients of Valcyte) and Valcyte (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: